Clinical Trial Biorepository and Archiving Solutions Market Report 2025

The clinical trial biorepository and archiving solutions market size has grown strongly in recent years. It will grow from $4.1 billion in 2024 to $4.43 billion in 2025 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to rising prevalence of pharmaceuticals, growing emphasis on molecular profiling, rising importance of data storage and management, rising demand for medical research, and rising demand for personalized medicine.

The clinical trial biorepository and archiving solutions market size is expected to see strong growth in the next few years. It will grow to $6.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to the increasing number of clinical trials, rising demand for cell and gene therapies, increasing focus on precision medicine, increasing adoption of digital technologies, and growing health industry. Major trends in the forecast period include developing standardized protocols, integration of cloud-based solutions, innovation in sample preservation techniques, advanced biorepository solutions, and advanced storage and data management systems.

The forecast of 8.1% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. research organizations by increasing costs of clinical trial biorepository services outsourced to Singapore and South Korea, potentially delaying drug development timelines and raising pharmaceutical research and development expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing number of clinical trials is expected to significantly drive the growth of the clinical trial biorepository and archiving solutions market. Clinical trials are research studies conducted on humans to evaluate the safety, effectiveness, and side effects of new medical treatments or drugs. This increase in clinical trials is largely due to advancements in medical research and the rise of personalized medicine, which demands more targeted and varied clinical testing. Clinical trial biorepository and archiving solutions play a key role in supporting this growth by ensuring secure long-term storage, easy retrieval of biological samples, and adherence to regulatory standards. These solutions improve data reliability and expedite future research. For example, a report from the Association of the British Pharmaceutical Industry (ABPI), published in November 2023, revealed that the number of clinical trials initiated annually in the UK increased by 4.3%, rising from 394 trials in 2021 to 411 in 2022. As a result, the growing number of clinical trials is contributing to the market expansion of clinical trial biorepository and archiving solutions.

Key players in the clinical trial biorepository and archiving solutions market are focusing on developing innovative technologies, such as state-of-the-art biorepository facilities, to enhance storage, data management, and compliance in clinical research. A state-of-the-art biorepository facility is an advanced storage and management center designed with cutting-edge technology to preserve biological samples and clinical trial data. For instance, in January 2025, Azenta Life Sciences, a U.S.-based biotech company, opened a state-of-the-art biorepository facility in Greater Boston to support biotech and life sciences industries with advanced sample storage and management. This facility streamlines the handling of research, clinical trials, and biobanking while providing secure and compliant offsite storage for clinical trials.

In July 2024, Tobin Scientific Inc., a U.S.-based laboratory and provider of biopharma cold chain, ambient storage, transport, and logistics services, acquired BioRepository Resources LLC for an undisclosed amount. Through this acquisition, Tobin Scientific aims to strengthen its biopharmaceutical storage capabilities, broaden its market presence, and solidify its position as a leader in the life sciences sector. BioRepository Resources LLC is a U.S.-based life sciences service provider specializing in clinical trial biorepository and archiving solutions.

Major players in the clinical trial biorepository and archiving solutions market are Thermo Fisher Scientific Inc., GE HealthCare, Labcorp Holdings Inc., IQVIA, ICON plc, Avantor Inc., VWR International LLC, Charles River Laboratories, Parexel, Clinigen Limited, Inotiv Inc., Medpace Holdings Inc., LabConnect LLC, Azenta Life Sciences, HSRL Holdings LLC, EPL Archives, Manuh Solutions LLC, EMINENT Services Corporation, Boca Biolistics LLC, Astoriom.

North America was the largest region in the clinical trial biorepository and archiving solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in clinical trial biorepository and archiving solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the clinical trial biorepository and archiving solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical trial biorepository and archiving solutions market consists of revenues earned by entities by providing services such as long-term archiving, regulatory compliance, data management, inventory tracking and sample retrieval. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial biorepository and archiving solutions market also includes sales of cryogenic freezers, biobanking software, automated sample storage systems and liquid nitrogen storage tanks. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment - many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The clinical trial biorepository and archiving solutions market research report is one of a series of new reports that provides clinical trial biorepository and archiving solutions market statistics, including the clinical trial biorepository and archiving solutions industry global market size, regional shares, competitors with the clinical trial biorepository and archiving solutions market share, detailed clinical trial biorepository and archiving solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical trial biorepository and archiving solutions industry. This clinical trial biorepository and archiving solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Clinical trial biorepository and archiving solutions involve the systematic management of biological samples, clinical data, and related documentation collected during and after clinical trials. These services ensure that biospecimens are stored under controlled, regulated conditions to preserve their integrity for future research, regulatory inspections, or further analysis.

The primary product categories include preclinical products and clinical products. Preclinical products refer to drug candidates, therapies, or medical devices that are still in the research and testing phase, undergoing laboratory and animal studies to evaluate safety, efficacy, and potential side effects before progressing to human trials. The services provided encompass both biorepository and archiving solutions. These solutions are applied across several areas, including research and development, clinical trials, regulatory compliance, and drug development. They serve a diverse range of end users, such as pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and academic institutions.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.